Abstract:Sirolimus (SRL) is a mammalian target of rapamycin (mTOR) inhibitor. The whole blood concentration of SRL is routinely monitored to tailor dosage and prevent toxicity. Currently, the enzyme multiplied immunoassay technique (EMIT) is often applied to perform therapeutic drug monitoring (TDM) of SRL, but the cross-reactivity with various metabolites is of great concern. A more specific method is required, such as liquid chromatography–tandem mass spectrometry (LC-MS/MS). However, no study on the method comparison of the EMIT and LC-MS/MS for the measurement of whole blood SRL concentration in children with vascular anomalies has been reported. This study developed a simple and sensitive LC-MS/MS assay for the determination of SRL. Meanwhile, consistency between LC-MS/MS and the EMIT was evaluated by linear regression and Bland–Altman analysis. Whole blood samples were deproteinized with methanol for erythrocyte lysis, and the resulting solution was injected into the LC-MS/MS system using the positive electrospray ionization mode. The multiple reaction monitoring transitions of m/z 931.7 → 864.6 and m/z 934.7 → 864.6 were used for SRL and SRL-d 3 as the internal standards, respectively. The analytes were separated on a C18 column with a gradient mobile phase (0.1 mM formic acid and 0.05 mM ammonium acetate in methanol/ultrapure water). Blood samples collected from children with vascular anomalies undergoing SRL therapy were tested by EMIT and by LC-MS/MS. The linear range of LC-MS/MS was 0.500–50.0 ng/ml and that of the EMIT was 3.50–30.0 ng/ml. A significant positive correlation between the two assays was established with a regression equation described as [ EMIT ] = 1.281 × [ LC−MS/MS ] + 2.450 ( r = 0.8361). Bland–Altman plots showed a mean concentration overestimation of 4.7 ng/ml [95% CI: (−3.1, 12.6)] and a positive bias of 63.1% [95% CI: (−36.1, 162.3)] generated by the EMIT more than that of by LC-MS/MS. In conclusion, the two methods were closely correlated, indicating that switching between the two methods is feasible. Considering the overestimation nature of the EMIT assay, switching from the EMIT to the LC-MS/MS method deserves close attention and necessary re-evaluation for the target therapeutic reference range, may be required when methods are switched within the same clinical laboratory or results are compared between different laboratories.

Determination of Sirolimus in Rat Whole Blood by HPLC-MS/MS

Determination of sirolimus in whole blood of beagle dog by UPLC-MS/MS

HPLC Method for the Determination of Sirolimus in Human Plasma

Determination of blood concentrations of sirolimus in patients after renal transplantation

UPLC-MS/MS测定beagle犬内西罗莫司血药浓度

Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction

Determination of the Plasma Sirolimus Concentrations in Patients after Renal Transplantation by HPLC Method

A Simple and Sensitive LC–MS/MS Method for Simultaneous Determination of Temsirolimus and Its Major Metabolite in Human Whole Blood

Evaluation the methods for the determination of blood sirolimus concentrations and its clinical application

Establishment of LC-MS/MS Methodology for the Determination of Rapamycin Concentration in Rat Whole Blood

Development of UHPLC-MS/MS Method for Simultaneous Determination of Tacrolimus and Sirolimus in Human Whole Blood and Comparisons with Two Immunoassays

Determination of Sophoricoside and Genistein in Rat Plasma by HPLC-MS/MS

DETERMINATION OF SILIBININ CONCENTRATION IN RAT PLASMA BY RP-HPLC

Determination of simvastatin and its active metabolite simvastatin acid in rat plasma by HPLC-MS/MS

A simple and sensitive LC-MS/MS method for the determination of sotalol in rat plasma.

Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies

Determination of Pirfenidone in Rat Plasma by LC–MS-MS and Its Application to a Pharmacokinetic Study

A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat

Determination of Gomisin A in Rat Plasma by HPLC-MS and Its Application

Determination of Imatinib in Rat Plasma by HPLC and Study of Its Pharmacokinetics

Determination of pinostrobin in rat plasma by LC-MS/MS: application to pharmacokinetics.